Literature DB >> 12852661

Non-AIDS-defining cancer in HIV-infected people.

Timothy P Cooley1.   

Abstract

Since the advent of HAART, the natural history of HIV disease has been changing, with decreased risk of life-threatening opportunistic infections and prolonged survival. Concurrently, a variety of non-AIDS-defining cancers have been reported with increased incidence in HIV-infected adults, including anal cancer, Hodgkin's disease, head and neck cancer, testicular cancer, lung cancer, colon cancer, basal cell cancer, squamous cell cancer of the skin, and melanoma. It appears that these tumors may have a more aggressive clinical course in HIV-infected people. Available data, however, suggest that antitumor response and survival in HIV-infected people with malignancy are improved in people with higher CD4 counts. The possible mechanisms for the increased incidence and altered clinical course of these malignancies in HIV-infected people remain unclear.

Entities:  

Mesh:

Year:  2003        PMID: 12852661     DOI: 10.1016/s0889-8588(03)00038-8

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  10 in total

1.  HIV/AIDS and Colorectal Cancer: A Review in the Era of Antiretrovirals.

Authors:  Ryan M Ford; Matthew M McMahon; Mohammad A Wehbi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

Review 2.  Lung cancer in HIV infected patients: facts, questions and challenges.

Authors:  J Cadranel; D Garfield; A Lavolé; M Wislez; B Milleron; C Mayaud
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

3.  Colorectal cancer screening in human immunodeficiency virus population: Are they at average risk?

Authors:  Suresh Kumar Nayudu; Bhavna Balar
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

Review 4.  Screening HIV-infected patients for non-AIDS-defining malignancies.

Authors:  Adrienne A Phillips; Jessica E Justman
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

5.  Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention.

Authors:  Chang-Hua Chen; Chih-Yuan Chung; Li-Hsuan Wang; Che Lin; Hsiu-Li Lin; Hsiu-Chen Lin
Journal:  BMC Cancer       Date:  2015-03-16       Impact factor: 4.430

6.  Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting.

Authors:  Carolyn A Brown; Gita Suneja; Neo Tapela; Abigail Mapes; Malebogo Pusoentsi; Mompati Mmalane; Ryan Hodgeman; Matthew Boyer; Zola Musimar; Doreen Ramogola-Masire; Surbhi Grover; Memory Nsingo-Bvochora; Mukendi Kayembe; Jason Efstathiou; Shahin Lockman; Scott Dryden-Peterson
Journal:  Oncologist       Date:  2016-04-06

7.  Neuroendocrine tumour in a patient with neurofibromatosis type 1 and HIV.

Authors:  Juliane Hiesgen; Ebrahim Variava
Journal:  South Afr J HIV Med       Date:  2015-06-26       Impact factor: 2.744

8.  South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment.

Authors:  Herbert Cubasch; Paul Ruff; Maureen Joffe; Shane Norris; Tobias Chirwa; Sarah Nietz; Vinay Sharma; Raquel Duarte; Ines Buccimazza; Sharon Čačala; Laura W Stopforth; Wei-Yann Tsai; Eliezer Stavsky; Katherine D Crew; Judith S Jacobson; Alfred I Neugut
Journal:  J Glob Oncol       Date:  2017-04

9.  Patient Factors Associated With Delays in Obtaining Cancer Care in Botswana.

Authors:  Rohini K Bhatia; Sarah Rayne; William Rate; Lame Bakwenabatsile; Barati Monare; Chidinma Anakwenze; Preet Dhillon; Mohan Narasimhamurthy; Scott Dryden-Peterson; Surbhi Grover
Journal:  J Glob Oncol       Date:  2018-08

10.  Dyspnea in an HIV Patient: A Not so Typical Presentation of Lung Adenocarcinoma.

Authors:  Anthony Kunnumpurath; Christopher Bryan Huang; Diana Jacob
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.